The ABCs of bioterrorism for veterinarians, focusing on Category A agents

Journal of the American Veterinary Medical Association

Volumn 224, Issue 7, 2004, Pages 1084-1095

  Davis, Radford G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CARE; ANIMAL DISEASE; ANIMAL HEALTH; ANIMAL RIGHTS; ANIMAL WELLBEING; ANTHRAX; BIOLOGICAL WARFARE; BOTULISM; CLASSIFICATION; HEMORRHAGIC FEVER; INFECTION RISK; NONHUMAN; PLAGUE; REVIEW; RISK FACTOR; SARS CORONAVIRUS; SMALLPOX; TULAREMIA; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; BIOTERRORISM; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; HUMANS; MORTALITY; PUBLIC HEALTH; UNITED STATES; VETERINARIANS; VETERINARY MEDICINE; ZOONOSES;

ANIMALIA; ANTHRAX; CORONAVIRUS; SARS CORONAVIRUS; VARIOLA VIRUS;

EID: 1642441802     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.1084     Document Type: Review

References (135)

1. Barton R. The application of the UNSCOM experience to international biological arms control. Crit Rev Microbiol 1998;24:219-233.
2. Mangold T, Goldberg J. Plague wars: the terrifying reality of biological warfare. New York: St Martin's Press, 1999.
3. Miller J, Engelberg S, Broad W. Germs: biological weapons and America's secret war. New York: Simon & Schuster, 2001;15-33.
4. Zilinskas RA. Iraq's biological weapons: the past as future? JAMA 1997;278:418-424.
5. World Health Organization. Severe acute respiratory syndrome. Wkly Epidemiol Rec 2003;78:81-83.
6. World Health Organization. Cumulative number of reported probable cases of SARS. Available at: www.who.int/csr/sars/country/2003_07_11/en/. Accessed Jul 31, 2003.
7. Centers for Disease Control and Prevention. Update: Severe acute respiratory syndrome - worldwide and United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:664-665.
8. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976.
9. Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966.
10. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1398.
11. Breiman RF, Evans MR, Preiser W, et al. Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1037-1041.
12. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276-278.
13. World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Available at: www.who.int/csr/sars/en/index.html. Accessed Nov 20, 2003.
14. Centers for Disease Control and Prevention. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders - Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep 2003;52:986-987.
15. Martina BEE, Haagmans BL, Kuiken T, et al. SARS virus infection of cats and ferrets. Nature 2003;425:915.
16. Centers for Disease Control and Prevention. Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003;52:537-540.
17. Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003;52:642-646.
18. Centers for Disease Control and Prevention. Monkeypox infections in animals: updated interim guidance for veterinarians. Available at: www.cdc.gov/ncidod/monkeypox/index.htm. Accessed Dec 10, 2003.
19. Gage KL, Montenieri JA. The role of predators in the ecology, epidemiology, and surveillance of plague in the United States, in Proceedings. 16th Vertebr Pest Conf 1994;200-206.
20. Clark RK, Jessup DA, Hird DW, et al. Serologic survey of California wild hogs for antibodies against selected zoonotic disease agents. J Am Vet Med Assoc 1983;183:1248-1251.
21. Warner RD, Marsh WW. Rocky Mountain spotted fever. J Am Vet Med Assoc 2002;221:1413-1417.
22. Gage KL. Plague surveillance. In: Plague manual: epidemiology, distribution, surveillance and control. Geneva: World Health Organization, 1999;135-161.
23. van der Schalie WH, Gardner HS Jr, Bantle JA, et al. Animals as sentinels of human health hazards of environmental chemicals. Environ Health Perspect 1999;107:309-315.
24. Huxsoll DL, Patrick WC III, Parrott CD. Veterinary services in biological disasters. J Am Vet Med Assoc 1987;190:714-722.
25. Todd FA. Biological warfare against our livestock. North Am Vet 1952;33:689-693.
26. Federal Bureau of Investigation. Terrorism in the United States, 1999. Washington, DC: Federal Bureau of Investigation, Counterterrorism, Threat Assessment and Warning Unit, Counterterrorism Division, 1999.
27. Lesser IO, Hoffman B, Arquilla J, et al. Countering the new terrorism. Washington, DC: RAND, 1999.
28. September 11, 2001 Victims. September 11, 2001 victims home page. Available at: www.september11victims.com/september11victims/. Accessed May 6, 2003.
29. Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8:1019-1028.
30. Török TJ, Tauxe RV, Wise RP, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 1997;278:389-395.
31. United States Department of State. Patterns of global terrorism - 2001. Washington, DC: US Department of State, 2002.
32. Carus WS. Center for Counterproliferation Research, National Defense University Working paper: bioterrorism and biocrimes. The illicit use of biological agents since 1900. Available at: www.ndu.edu/centercounter/Full_Doc.pdf. Accessed Jun 1, 2002.
33. Stern J. The ultimate terrorists. London: Harvard University Press, 1999.
34. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:225-230.
35. Bell JH. Anthrax and the wool trade. Am J Public Health 2002;92:754-757.
36. Brachman PS. Inhalation anthrax. Ann N Y Acad Sci 1980;353:83-93.
37. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-944.
38. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002. JAMA 1999;281:2236-2252.
39. Friedlander AM. Anthrax. In: Zajtchuk R, Bellamy RF, Sidell FR, et al, eds. Textbook of military medicine, medical aspects of chemical and biological warfare. Part I. Washington, DC: Office of The Surgeon General, Department of the Army, 1997;467-478.
40. Turnbull PCB. Guidelines for the surveillance and control of anthrax in humans and animals. 3rd ed. Geneva: World Health Organization, 2002.
41. Centers for Disease Control and Prevention. Human anthrax associated with an epizootic among livestock - North Dakota, 2000. MMWR Morb Mortal Wkly Rep 2001;50:677-680.
42. Swartz MN. Recognition and management of anthrax - an update. N Engl J Med 2001;345:1621-1626.
43. Cieslak TJ, Eitzen EM Jr. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis 1999;5:552-555.
44. Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol 1978;9:594-597.
45. Friedlander AM, Welkos SL, Pitt MLM, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 1993;167:1239-1242.
46. Glassman HN. Industrial inhalational anthrax. Bacteriol Rev 1966;30:657-659.
47. Jefferds DM, Laserson K, Fry AM, et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1138-1144.
48. Centers for Disease Control and Prevention. Additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep 2003;50:1142, 1151.
49. Peters CJ, Hartley DM. Anthrax inhalation and lethal human infection. Lancet 2002;359:710-711.
50. Williams AA, Parashar UD, Stoica A, et al. Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001. Emerg Infect Dis 2002;8:1078-1082.
51. Whitford HW, Hugh-Jones ME. Anthrax. In: Beran GW, Steele JH, eds. Handbook of zoonoses, section A: bacterial, rickettsial, chlamydial, and mycotic zoonoses. 2nd ed. Boca Raton, Fla: CRC Press Inc, 1994;61-82.
52. Radostits OM, Gay CC, Blood DC, et al. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. 9th ed. London: Harcourt Publishers Ltd, 2000;747-751.
53. Greene CE, Prescott JF. Streptococcal and other gram-positive bacterial infections. In: Green CE, eds. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;205-214.
54. McGee ED, Fritz DL, Ezzell JW, et al. Anthrax in a dog. Vet Pathol 1994;31:471-473.
55. Gleiser CA, Gochenour WS, Ward MK. Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores. J Comp Pathol 1968;78:445-449.
56. Bales ME, Dannenberg AL, Brachman PS, et al. Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001. Emerg Infect Dis 2002;8:1163-1174.
57. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997;3:83-94.
58. World Health Organization. Health aspects of chemical and biological weapons. Geneva: World Health Organization, 1970;1-132.
59. Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood mail processing and distribution center - District of Columbia, October, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1129-1133.
60. Dewan PK, Fry AM, Laserson K, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2003;8:1066-1072.
61. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-411.
62. American Public Health Association. In: Chin J, eds. Control of communicable disease manual. 17th ed. Washington, DC: American Public Health Association, 2000;70-74.
63. Middlebrook JL, Franz DR. Botulinum toxins. In: Zajtchuk R, Bellamy RF, Sidell FR, et al, eds. Textbook of military medicine, medical aspects of chemical and biological warfare. Part I. Washington, DC: Office of The Surgeon General, Department of the Army, 1997;643-654.
64. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon. JAMA 2001;285:1059-1070.
65. Barsanti JA. Botulism. In: Greene CE, eds. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;263-267.
66. Radostits OM, Gay CC, Blood DC, et al. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. 9th ed. London: Harcourt Publishers Ltd, 2000;757-760.
67. Poland JD, Quan TJ, Barnes AM. Plague. In: Beran GW, Steele JH, eds. Handbook of zoonoses, section A: bacterial, rickettsial, chlamydial, and mycotic zoonoses. 2nd ed. Boca Raton, Fla: CRC Press Inc, 1994;93-112.
68. Tikhomirov E.Epidemiology and distribution of plague. Plague manual: epidemiology, distribution, surveillance and control. Geneva: World Health Organization, 1999;11-42.
69. Orloski KA, Lathrop SL. Plague: a veterinary perspective. J Am Vet Med Assoc 2003;222:444-448.
70. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon. JAMA 2000;283:2281-2290.
71. Poland JD, Dennis DT. Diagnosis and clinical manifestations. In: Plague manual: epidemiology, distribution, surveillance and control. Geneva: World Health Organization, 1999;43-53.
72. Perry RD, Fetherston JD. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997;10:35-66.
73. Christie AB, Chen TH, Elsberg SS. Plague in camels and goats: their role in human epidemics. J Infect Dis 1980;141: 724-726.
74. Orloski KA, Eidson M. Yersinia pestis infection in three dogs. J Am Vet Med Assoc 1995;207:316-318.
75. Eidson M, Thilsted JP, Rollag OJ. Clinical, clinicopathologic, and pathologic features of plague in cats: 119 cases (1977-1988). J Am Vet Med Assoc 1991;199:1191-1197.
76. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated human plague in the western US, 1977-1998. Clin Infect Dis 2000;20:893-900.
77. Ackelsberg J, Layton M. New York County Medical Society. 2002 Health Alert #36. Two cases of travel-associated bubonic plague in New York City. Available at: www.nycms.org/article_view.php3?view=529&part=1. Accessed Dec 12, 2003.
78. CNN. Bubonic plague suspected in NYC visitors. Available at: www.cnn.com/2002/US/Northeast/11/06/ny.plague/. Accessed Dec 12, 2003.
79. Centers for Disease Control and Prevention. Imported plague-New York City, 2002. MMWR Morb Mortal Wkly Rep 2003;52:725-728.
80. Baxby D, Bennett M. Poxvirus zoonoses. J Med Microbiol 1997;46:17-20, 28-33.
81. Fenner E Poxviral Zoonoses. In: Beran GW, Steele JH, eds. Handbook of zoonoses, section B: viral zoonoses. 2nd ed. Boca Raton, Fla: CRC Press Inc, 1994;485-503.
82. Damaso CR, Esposito JJ, Condit RC, et al. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virology 2000;277:439-449.
83. Pattyn SR. Monkeypoxvirus infections. Rev Sci Tech 2000;19:92-97.
84. Sullivan NJ, Geisbert TW, Geisbert JB, et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003;424:681-684.
85. Fenner F. Poxviruses. In: Fields B, Knipe D, Howley P, et al, eds. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996;2673-2702.
86. Kolhapure RM, Deolanker RP, Tupe CD, et al. Investigation of buffalopox outbreaks in Maharashtra State during 1992-1996. Indian J Med Res 1997;106:441-446.
87. Sawhney AN, Singh AK, Malik BS. Goat-pox: an anthropozoonosis. Indian J Med Res 1972;60:683-684.
88. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization, 1988;479-480.
89. Baxby D, Ramyar H, Hessami M, et al. Response of camels to intradermal inoculation with smallpox and camelpox viruses. Infect Immun 1975;11:617-621.
90. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization, 1988;191-194.
91. Henderson DA, lnglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. JAMA 1999;281:2127-2137.
92. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization, 1988;189.
93. Pilch R. Monterey Institute of International Studies. Smallpox: threat, vaccine, and U.S. policy, Part 1 of 6. Available at: cns.miis.edu/pubs/week/030106.htm. Accessed Mar 5, 2003.
94. Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva: World Health Organization, 1988;278.
95. Centers for Disease Control and Prevention. People who should not get the smallpox vaccine. Smallpox fact sheet. Available at: www.bt.cdc.gov/agent/smallpox/vaccination/contraindicationspublic.asp. Accessed Dec 12, 2003.
96. Grabenstein JD, Winkenwerder W Jr. US military smallpox vaccination program experience. JAMA 2003;289:3278-3282.
97. Centers for Disease Control and Prevention. Smallpox vaccination program report status and adverse events. Available at: www.cdc.gov/od/oc/media/smpxrprt.htm. Accessed Dec 10, 2003.
98. Lane JM, Ruben FL, Neff JM, et al. Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med 1969;281:1201-1208.
99. Lane JM, Ruben FL, Neff JM, et al. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970;122:303-309.
100. Centers for Disease Control and Prevention. Update: cardiac-related events during the civilian smallpox vaccination program-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:492-496.
101. Centers for Disease Control and Prevention. Cardiac deaths after a mass smallpox vaccination campaign-New York City, 1947. MMWR Morb Mortal Wkly Rep 2003;52:933-936.
102. Ault A. US smallpox vaccine programme stalls as volunteers balk. Lancet 2003;361:1626.
103. Dekking F. Cowpox and vaccinia. In: van der Hoeden J, ed. Zoonoses. Amsterdam: Elsevier Pub Co, 1964;411-418.
104. Lum GS, Soriano F, Trejos A, et al. Vaccinia epidemic and epizootic in El Salvador. Am J Trop Med Hyg 1967;16:332-338.
105. Centers for Disease Control and Prevention. Basic information about monkeypox. Available at: www.cdc.gov/ncidod/monkeypox/factsheet.htm. Accessed Dec 10, 2003.
106. Fine PE, Jezek Z, Grab B, et al. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988;17:643-650.
107. Hutin YJ, Williams RJ, Malfait P, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996-1997. Emerg Infect Dis 2001;7:434-438.
108. Centers for Disease Control and Prevention. Smallpox vaccination and monkeypox. Available at: www.cdc.gov/ncidod/monkeypox/smallpoxvaccine_mpox.htm. Accessed Dec 10, 2003.
109. Ellis J, Oyston PCF, Green M, et al. Tularemia. Clin Microbiol Rev 2002;15:631-646.
110. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon. JAMA 1999;285:2763-2773.
111. Feldman KA. Tularemia. J Am Vet Med Assoc 2003;222: 725-730.
112. United States Army Medical Research Institute of Infectious Diseases. Tularemia. In: Kortepeter M, ed. Medical management of biological casualties handbook: the blue book. 4th ed. Fort Detrick, Md: US Army Medical Research Institute of Infectious Diseases, 2001;69-77.
113. Pearson A. Tularemia. In: Palmer SR, Soulsby L, Simpson DIH, eds. Zoonoses. New York: Oxford University Press, 1998; 267-279.
114. Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 2001;345:1601-1606.
115. Centers for Disease Control and Prevention. Tularemia-United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2002;51:181-184.
116. Radostits OM, Gay CC, Blood DC, et al. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. 9th ed. London: Harcourt Publishers Ltd, 2000;857-858.
117. Kaufmann AF. Tularemia. In: Greene CE, eds. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;300-302.
118. Jahrling PB. Viral hemorrhagic fevers. In: Zajtchuk R, Bellamy RF, Sidell FR, et al, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Part I. Washington, DC: Office of The Surgeon General, Department of the Army, 1997;591-602.
119. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons. JAMA 2002;287:2391-2405.
120. Clement JP. Hantavirus. Antiviral Res 2003;57:121-127.
121. Bray M. Defense against filoviruses used as biological weapons. Antiviral Res 2003;57:53-60.
122. Peters CJ. Are hemorrhagic fever viruses practical agents for biological terrorism? In: Scheld WM, Craig WA, Hughes JM, eds. Emerging infections 4. Washington, DC: American Society for Microbiology, 2000;201-209.
123. Peters CJ, Jahrling PB, Khan AS. Patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol Suppl 1996;11:141-168.
124. Charrel RN, Lamballerie X. Arenaviruses other than Lassa virus. Antiviral Res 2003;57:89-100.
125. Swanepoel R. Crimean-congo hemorrhagic fever. In: Beran GW, Steele JH, eds. Handbook of zoonoses, section B: viral zoonoses. 2nd ed. Boca Raton, Fla: CRC Press Inc, 1994;149-161.
126. Peters CJ, Linthicum KJ. Rift Valley fever. In: Beran GW, Steele JH, eds. Handbook of zoonoses, section B: viral zoonoses. 2nd ed. Boca Raton, Fla: CRC Press Inc, 1994;125-138.
127. Office International des Epizooties. Rift Valley fever. Available at: www.oie.int/eng/maladies/fiches/a_A080.htm. Accessed Mar 27, 2003.
128. Radostits OM, Gay CC, Blood DC, et al. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. 9th ed. London: Harcourt Publishers Ltd, 2000;1042-1044.
129. Gargan TP II, Clark GG, Dohm DJ, et al. Vector potential of selected North American mosquito species for Rift Valley fever virus. Am J Trop Med Hyg 1988;38:440-446.
130. Barnhard BJH. Rift Valley fever. In: Aiello SE, Mays A, eds. The Merck veterinary manual. 8th ed. Whitehouse Station, NJ: Merck & Co Inc, 1998;541-542.
131. Greene CE, Baldwin CA. Arboviral infections. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;131-132.
132. Niklasson B, Peters CJ, Bengtsson E, et al. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans. Vaccine 1985;3:123-127.
133. Pittman PR, Liu CT, Cannon TL, et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans. Vaccine 1999;18:181-189.
134. Dandawate DN, Desai GB, Achar TR, et al. Field evaluation of formalin inactivated Kyasanur forest disease virus tissue culture vaccine in three districts of Karnataka state. Indian J Med Res 1994;99:152-158.
135. Geisbert TW, Pushko P, Anderson K, et al. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002;8:503-507.